
Apollo Hospitals Posts 36% YoY Rise in Net Profit to ₹529 Crore in Q4, Declares Final Dividend of ₹10 per Share
Apollo Hospitals Enterprise Reports Strong Growth in Q4FY26 and FY26 Financial Results
Apollo Hospitals Enterprise, one of the country's largest private hospital chains, announced its March quarter and FY26 financial results on May 20 after market hours, reporting robust growth in revenue and EBITDA across all three business verticals as well as at the consolidated level.
The company posted a 36% year-on-year (YoY) rise in consolidated net profit to ₹529 crore, compared to ₹389 crore in the same quarter last year. On the top line, revenue grew 18% YoY to ₹6,605 crore from ₹5,592 crore reported in the corresponding period last year.
At the operating level, EBITDA stood at ₹1,011 crore, marking a 31.5% YoY increase compared to ₹769 crore in Q4FY25, while EBITDA margins expanded by 154 basis points to 15.3%.
Read also: Treasury Yields Experience Largest Increase in Two Weeks Following Release of Labor Market Data
| Segment | Q4FY26 Revenue | Q4FY25 Revenue | YoY Growth |
|---|---|---|---|
| Healthcare Services | ₹3,268 crore | ₹2,813 crore | 16% |
| Apollo Health and Lifestyle | ₹489 crore | ₹396 crore | 24% |
| Apollo HealthCo | ₹2,848 crore | ₹2,372 crore | 20% |
In terms of segments, the healthcare services division posted 16% YoY revenue growth to ₹3,268 crore, while EBITDA rose 14% to ₹781 crore with margins at 23.9%. Apollo Health and Lifestyle delivered a strong performance, with revenue increasing 24% YoY to ₹489 crore and EBITDA surging 58% to ₹75 crore. The segment also turned profitable, reporting a PAT of ₹10 crore against a loss of ₹4 crore a year before.
Meanwhile, Apollo HealthCo reported 20% YoY revenue growth at ₹2,848 crore, while EBITDA jumped sharply to ₹156 crore from ₹36 crore in Q4FY25. PAT for the segment rose significantly to ₹107 crore from ₹9 crore last year.
For the full financial year FY26, the company reported consolidated revenue growth of 16% YoY to ₹25,229 crore from ₹21,794 crore in FY25. EBITDA rose to ₹3,769 crore from ₹3,022 crore in the previous fiscal, despite Apollo 24/7-related costs of ₹467 crore during the year, including a non-cash ESOP charge of ₹118 crore.
Read also: US-Iran Tensions Spark Uptick in Oil Prices Amid Global Market Decline
On the bottom line, the net profit increased to ₹1,942 crore from ₹1,446 crore in FY25. Meanwhile, the gross merchandise value (GMV) of Apollo 24/7 stood at ₹2,037 crore during FY26.
The company announced a final dividend of ₹10 per share for FY26 and fixed Friday, August 14, 2026, as the record date to determine eligible shareholders entitled to receive the dividend, as well as for participation in the Annual General Meeting (AGM).
The Board of Directors recommended a final dividend of ₹10 per equity share (200%) of the face value of ₹5 per share for FY2025-26. The dividend recommended by the Board is subject to the approval of shareholders at the ensuing Annual General Meeting of the Company.
Investor Takeaway
Apollo Hospitals reported a 36% YoY rise in net profit to ₹529 crore in Q4, indicating strong growth in revenue and EBITDA.
More in Economy

Treasury Yields Experience Largest Increase in Two Weeks Following Release of Labor Market Data

US-Iran Tensions Spark Uptick in Oil Prices Amid Global Market Decline

MoSPI Releases Uniform Norms for DDP Estimates with 2022-23 Base Year
